| |
| Device | SELUTION SLR™ 014 PTCA Drug-Eluting Balloon |
| Generic Name | Drug-eluting percutaneous transluminal coronary angioplasty catheter |
| Applicant | MedAlliance, LLC 4 Jenner Suite 190 Irvine, CA 92618 |
| PMA Number | P250041 |
| Supplement Number | S001 |
| Date Received | 10/08/2026 |
| Decision Date | 11/06/2026 |
| Product Code |
OOB |
| Advisory Committee |
Cardiovascular |
| Clinical Trials | NCT04280029
|
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Postapproval Study Protocol |
| Expedited Review Granted? | No |
| Combination Product | Yes |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement SELUTION4ISR Continued Follow-up Study will evaluate the long-term safety and effectiveness of the SELUTION SLR PTCA DEB in 418 subjects from the premarket study (SELUTION4ISR). Subjects will be followed annually through 5 years post-procedure, and all efforts will be made to minimize the amount of missing long-term data. |